AI-generated analysis. Always verify with the original filing.
On March 12, 2026, 60 Degrees Pharmaceuticals, Inc. filed an updated legal opinion of counsel from Sichenzia Ross Ference Carmel LLP regarding the shares of common stock. The filing includes the opinion as Exhibit 5.1 and the related consent as Exhibit 23.1.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On March 12, 2026, 60 Degrees Pharmaceuticals, Inc. (the “Company”) filed an updated legal opinion of counsel regarding the shares of common stock
Financial Statements and Exhibits (a) Exhibits Number Description 5.1 Opinion of Sichenzia Ross Ference Carmel LLP 23.1 Consent of Sichenzia Ross Ference Carmel